Biodesix (BDSX) EBT Margin Growth (3y) (2022 - 2026)
Biodesix (BDSX) EBT Margin Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -211.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 399.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 28.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -317.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 4,440.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 3,000.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 135.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -2.00 |
| 10 | Biodesix | 220.74 Mn | 195.16 Mn | 21.35 Mn | 68,049.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68,049.00 |
| Dec 31, 2025 | 8,360.00 |
| Sep 30, 2025 | 20,415.00 |
| Jun 30, 2025 | 10,846.00 |
| Mar 31, 2025 | 19,947.00 |
| Dec 31, 2024 | 10,205.00 |
| Sep 30, 2024 | 31,507.00 |
| Jun 30, 2024 | 20,739.00 |
| Mar 31, 2024 | 5,835.00 |
| Dec 31, 2023 | -7,830.00 |
| Sep 30, 2023 | 590.00 |
| Jun 30, 2023 | -8,704.00 |
| Mar 31, 2023 | -51,989.00 |
| Dec 31, 2022 | -5,724.00 |
| Sep 30, 2022 | -6,611.00 |